News

Boehringer Ingelheim and Eli Lilly and Company announced an academic collaboration with the University of Oxford to investigate the effects of Jardiance on the progression of kidney…
Read More...

Almac Group announced that it has expanded its US commercial packaging capabilities at its Audubon, PA facility. Addressing increased client demand of developing and bringing more…
Read More...

BioAscent Discovery Limited has announced the launch of a comprehensive suite of integrated drug discovery services with immediate effect. Dr Phil Jones will be joining as Chief…
Read More...

MilliporeSigma announced a partnership with Oxford University's Jenner Institute to develop more robust and scalable vaccine manufacturing processes. This partnership, as well as plans…
Read More...

GSK and Orchard Therapeutics announced a strategic agreement, under which GSK will transfer its portfolio of approved and investigational rare disease gene therapies to Orchard,…
Read More...

Sanofi is investing €350 million (CAD $500 million) for the construction of a new state-of-the-art vaccine manufacturing facility at the Sanofi Pasteur Canadian headquarters in Toronto,…
Read More...

“This milestone showcases the productivity of our collaboration with LEO Pharma, marking the final step before ARGX-112 may enter clinical development. It triggers the third of three…
Read More...

Ionis Pharmaceuticals announced that it has licensed IONIS-AZ6-2.5-LRx, or AZD2693, to AstraZeneca following advancement of the drug into development. IONIS-AZ6-2.5-LRx is designed to…
Read More...

Amgen announced plans to build a new state-of-the-art next-generation biomanufacturing plant at its campus in West Greenwich, R.I. The new plant, the first of its kind in the United…
Read More...

Alexion Pharmaceuticals and Wilson Therapeutics AB (publ) announced that Alexion has made a recommended public cash offer to the shareholders in Wilson Therapeutics to acquire all…
Read More...

Lonza is opening the world’s largest dedicated cell-and-gene-therapy facility, which was built in anticipation of the rising demand from developers of cell and gene therapies – the next…
Read More...

Halo Pharma, a rapidly growing contract development and manufacturing organization (CDMO), offers more than 30 years’ direct experience in the production of topical drug products – from…
Read More...

Bristol-Myers Squibb Company and the Harvard Fibrosis Network of the Harvard Stem Cell Institute announce a research collaboration to discover and develop potential new therapies for…
Read More...

Protagen AG and Gustave Roussy have announced the start of a collaboration to utilize Protagen’s SeroTag technology to help identify biomarkers that predict and monitor immune-related…
Read More...

Evotec AG announced a strategic collaboration with Petra Pharma Corporation. Through the collaboration, Petra will access Evotec's INDiGO platform to accelerate the development of its…
Read More...

Veracyte, Inc. announced a research collaboration through which Loxo Oncology will access Veracyte’s new Afirma Xpression Atlas platform to advance its development of highly selective…
Read More...

Lyophilization Services of New England (LSNE) announced a strategic plan to expand its Quality Control (QC) laboratory in Bedford, NH, and provide new employment opportunities for its…
Read More...

Inovio Pharmaceuticals and CEPI – the Coalition for Epidemic Preparedness Innovations – announced a partnership under which Inovio will develop vaccine candidates against Lassa fever…
Read More...

Zealand Pharma reports that it has engaged in a collaboration with Roche Diabetes Care for the Phase 3 trials with dasiglucagon for treatment of congenital hyperinsulinism (CHI).…
Read More...

Promethera Biosciences SA announced that it has acquired Baliopharm AG, a Swiss biopharmaceutical company focused on the development of targeted biological therapies for immune mediated…
Read More...